Chad Kolean

Chief Financial Officer at VIVEX Biologics

Chad Kolean joined VIVEX Biologics in 2019 and brings more than 30 years of financial services and accounting experience, having worked for a variety of privately held and publicly traded healthcare companies. Prior to joining VIVEX Biologics, Mr. Kolean was CFO and Treasurer for Titan Spine, where he helped lead the process that ultimately resulted in Titan’s acquisition by Medtronic.

Before Titan Spine, Mr. Kolean served as CFO and Treasurer for Cellectar Biosciences, a public clinical-stage biopharmaceutical company. He also served as CFO and Treasurer for Pioneer Surgical Technology, Inc., a $100M global manufacturer and distributor of spinal, biological, and orthopedic implants, until the company’s merger with RTI Surgical.

Beyond his significant healthcare experience, Mr. Kolean held a variety of leadership positions of increasing responsibility outside the industry, with companies such as Tomotherapy, Metavante Corporation, Snap-On, Herman Miller, Kaydon Corporation, and Arthur Andersen.

Timeline

  • Chief Financial Officer

    Current role

View in org chart